Roldan G, Tricarico C, Brown Jr R
Gastroenterol Hepatol (N Y). 2025; 20(11):662-671.
PMID: 39886332
PMC: 11775998.
Yoladi F, Burmaoglu E, Palabiyik S
Eurasian J Med. 2024; 55(1):82-90.
PMID: 39109811
PMC: 11075036.
DOI: 10.5152/eurasianjmed.2023.23345.
Han J, Lee C, Jeong H, Jeon S, Lee M, Lee H
J Biomed Sci. 2024; 31(1):54.
PMID: 38790021
PMC: 11127441.
DOI: 10.1186/s12929-024-01042-5.
Rodriguez-Agudo R, Gonzalez-Recio I, Serrano-Macia M, Bravo M, Petrov P, Blaya D
JHEP Rep. 2024; 6(1):100918.
PMID: 38192540
PMC: 10772393.
DOI: 10.1016/j.jhepr.2023.100918.
Blaney H, Tapper E
Clin Liver Dis (Hoboken). 2023; 21(5):143-146.
PMID: 37936926
PMC: 10627589.
DOI: 10.1097/CLD.0000000000000054.
Protects Rats against CCl-Induced Hepatic Injuries through Modulation of an Unfolded Protein Response Pathway and Pro-Inflammatory Intermediates.
Batool R, Khan M, Ijaz M, Naz I, Batool A, Ali S
Molecules. 2023; 28(5).
PMID: 36903503
PMC: 10004795.
DOI: 10.3390/molecules28052257.
Epidemiology and Disease Burden of Alcohol Associated Liver Disease.
Aslam A, Kwo P
J Clin Exp Hepatol. 2023; 13(1):88-102.
PMID: 36647400
PMC: 9840073.
DOI: 10.1016/j.jceh.2022.09.001.
Genome Editing and Fatty Liver.
Hayat U, Siddiqui A, Farhan M, Haris A, Hameed N
Adv Exp Med Biol. 2022; 1396:191-206.
PMID: 36454468
DOI: 10.1007/978-981-19-5642-3_13.
Lipid alterations in chronic liver disease and liver cancer.
Paul B, Lewinska M, Andersen J
JHEP Rep. 2022; 4(6):100479.
PMID: 35469167
PMC: 9034302.
DOI: 10.1016/j.jhepr.2022.100479.
Epidemiology of Alcohol-Associated Liver Disease.
Han S, Yang Z, Zhang T, Ma J, Chandler K, Liangpunsakul S
Clin Liver Dis. 2021; 25(3):483-492.
PMID: 34229835
PMC: 8996817.
DOI: 10.1016/j.cld.2021.03.009.
The History of Alcoholic Liver Disease: From an Unrecognized Disease to One of the Most Frequent Diseases in Hepatology.
Seitz H, Neuman M
J Clin Med. 2021; 10(4).
PMID: 33669694
PMC: 7921942.
DOI: 10.3390/jcm10040858.
Alcohol-Associated Liver Disease: East Versus West.
Charatcharoenwitthaya P, Liangpunsakul S, Piratvisuth T
Clin Liver Dis (Hoboken). 2021; 16(6):231-235.
PMID: 33489093
PMC: 7805304.
DOI: 10.1002/cld.920.
Epidemiology of non-alcoholic and alcoholic fatty liver diseases.
Mitra S, De A, Chowdhury A
Transl Gastroenterol Hepatol. 2020; 5:16.
PMID: 32258520
PMC: 7063528.
DOI: 10.21037/tgh.2019.09.08.
Alcohol Metabolizing Enzymes, Microsomal Ethanol Oxidizing System, Cytochrome P450 2E1, Catalase, and Aldehyde Dehydrogenase in Alcohol-Associated Liver Disease.
Jiang Y, Zhang T, Kusumanchi P, Han S, Yang Z, Liangpunsakul S
Biomedicines. 2020; 8(3).
PMID: 32143280
PMC: 7148483.
DOI: 10.3390/biomedicines8030050.
Metabolomic and Lipidomic Biomarkers for Premalignant Liver Disease Diagnosis and Therapy.
Beyoglu D, Idle J
Metabolites. 2020; 10(2).
PMID: 32012846
PMC: 7074571.
DOI: 10.3390/metabo10020050.
The Matrisome, Inflammation, and Liver Disease.
Dolin C, Arteel G
Semin Liver Dis. 2020; 40(2):180-188.
PMID: 31910448
PMC: 7195244.
DOI: 10.1055/s-0039-3402516.
Computational/experimental evaluation of liver metastasis post hepatic injury: interactions with macrophages and transitional ECM.
Hudson S, Miller H, Mahlbacher G, Saforo D, Beverly L, Arteel G
Sci Rep. 2019; 9(1):15077.
PMID: 31636296
PMC: 6803648.
DOI: 10.1038/s41598-019-51249-y.
LINC01093 Upregulation Protects against Alcoholic Hepatitis through Inhibition of NF-κB Signaling Pathway.
Shi X, Jiang X, Yuan B, Liu T, Tang Y, Che Y
Mol Ther Nucleic Acids. 2019; 17:791-803.
PMID: 31450097
PMC: 6716105.
DOI: 10.1016/j.omtn.2019.06.018.
Risk Behaviors Associated with Alcohol Consumption Predict Future Severe Liver Disease.
Hagstrom H, Hemmingsson T, Discacciati A, Andreasson A
Dig Dis Sci. 2019; 64(7):2014-2023.
PMID: 30761471
PMC: 6584217.
DOI: 10.1007/s10620-019-05509-6.
Alcoholic liver disease: Utility of animal models.
Lamas-Paz A, Hao F, Nelson L, Vazquez M, Canals S, Gomez Del Moral M
World J Gastroenterol. 2018; 24(45):5063-5075.
PMID: 30568384
PMC: 6288648.
DOI: 10.3748/wjg.v24.i45.5063.